Dr. Carroll is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-353-7171Fax+1 415-514-6195- Is this information wrong?
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1984 - 1986
- University of California (San Francisco)Residency, Urology, 1981 - 1984
- University of California (San Francisco)Residency, Surgery, 1979 - 1981
- Georgetown University School of MedicineClass of 1979
Certifications & Licensure
- NY State Medical License 1984 - Present
- CA State Medical License 1980 - 2025
- American Board of Urology Urology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer Start of enrollment: 1996 Dec 01
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer Start of enrollment: 2004 Feb 01
- Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer Start of enrollment: 2003 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Evaluation of URO17® to improve non-invasive detection of bladder cancer.Elizabeth Y Wang, Sholeh Jahanfard, Nam W Kim, Sima P Porten, Poonam Vohra, Peter R Carroll> ;Urologic Oncology. 2024 Mar 28
- The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.Chan, J., Neuhaus, J., Cowan, J., Kenfield, S., Van Blarigan, E., Tenggara, I., Broering, J., Braun, A., Simko, J., Carroll, P., Cooperberg, M.> ;Cancer. 2024 Jan 27
- High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.Liu, S., Hawley, S., Kunder, C., Hsu, E., Shen, M., Westphalen, L., Auman, H., Newcomb, L., Lin, D., Nelson, P., Feng, Z., Tretiakova, M., True, L., Vakar-Lopez, F., C...> ;Scientific Reports. 2024 Jan 4
- Join now to see all
Journal Articles
- First-in-Human Phase I Study of CTT1057, a Novel 18F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate CancerSpencer C Behr, Hao G Nguyen, Thomas A Hope, Kirsten L Greene, Matthew R Cooperberg, Robert R Flavell, Eric J Small, Peter R Carroll, Journal of Nuclear Medicine
Press Mentions
- Transgender Women Are Still at Risk for Prostate CancerApril 30th, 2023
- New PET Imaging Agent Alters Prostate Cancer Plan for More Than 40% of PatientsSeptember 10th, 2021
- ASCO GU 2021: Active Surveillance in 2021 and BeyondFebruary 11th, 2021
- Join now to see all
Grant Support
- Effectiveness Of Early Stage Prostate Cancer TreatmentNational Cancer Institute2009–2010
- MALE Reproductive Health Research Career Development ProgramEunice Kennedy Shriver National Institute Of Child Health &Human Development2006–2010
- UCSF Prostate Cancer SporeNational Cancer Institute2004–2008
- Molecular Effects Of Nutrition Supplements In ProstateNational Cancer Institute2005–2007
- Active Surveillance For Early Stage Prostate Cancer: Selection, MonitoringNational Cancer Institute2006
Professional Memberships
- Member
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
- Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California
- San Francisco VA Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: